Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana's recent $500 million, 5.7% senior unsecured notes due March 13, 2026 and $750 million, 5.5% senior unsecured notes due March 15, 2053. The outlook for these ratings is stable. The issuance aims to replace existing term loans, pre-fund upcoming maturities, and support general corporate purposes. Humana's financial leverage was approximately 42% as of Dec. 31, 2022, which is expected to moderate to about 40% long-term. Despite elevated leverage, earnings before interest and taxes coverage remains strong at over 10 times.
Humana Inc. (NYSE: HUM) announced a public offering of $1.25 billion in senior notes, comprised of $500 million due 2026 and $750 million due 2053. Pricing was set at 99.984% and 96.431% of the principal amount respectively. The offering is expected to close on March 13, 2023. Net proceeds, estimated at $1.211 billion, will repay a $500 million Delayed Draw Term Loan and cover general corporate purposes. The company is also vulnerable to various financial risks and regulatory changes, impacting profitability and operations, particularly due to its heavy government contract reliance.
Humana Inc. (NYSE: HUM) has announced that President and CEO Bruce D. Broussard will present to investors at the Cowen Health Care Conference on Tuesday, March 7, 2023, at 9:10 a.m. Eastern time. Investors can access a live audio webcast of the presentation on Humana's Investor Relations page, with a recommendation to log in 15 minutes early for system testing.
Humana is dedicated to improving health and well-being for its medical and specialty members while lowering costs. The company offers various clinical capabilities, including in-home care, behavioral health, and wellness solutions, aiming to simplify health care navigation for patients.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.885 per share, an increase of 12.4% from the previous $0.7875. The dividend is payable on April 28, 2023 to stockholders of record as of March 31, 2023. This reflects Humana's commitment to providing value to its shareholders while supporting integrated healthcare solutions. The company focuses on improving healthcare quality through in-home care, behavioral health, pharmacy services, and data analytics. Additional information is available on Humana's investor relations page.
Humana Inc. (NYSE: HUM) announces the Humana Foundation's new strategy aimed at advancing health equity by removing barriers in healthcare for seniors, veterans, and school-aged children. The Foundation will invest over
Humana Inc. (NYSE: HUM) has reinforced its long-standing relationship with ChenMed by signing a new five-year agreement, allowing Humana’s Medicare Advantage members access to in-network care at all of ChenMed’s locations. This collaboration supports both companies' commitment to senior-focused primary care, ensuring high-quality healthcare for members across Florida and beyond. Humana has approximately 8.6 million Medicare members, with 5.6 million enrolled in Medicare Advantage plans. The agreement further enhances ChenMed’s capabilities in delivering personalized concierge care, ensuring improved health outcomes for seniors.
Humana's Kentucky Medicaid Plan, Humana Healthy Horizons, announced a grant of $120,000 to three local organizations to enhance maternal health for Black mothers in Louisville. This initiative aims to address significant barriers, including access to prenatal care, reflected in Kentucky's low maternal health ratings. Black women experience a 2.9 times higher maternal mortality rate than white women in the U.S., underscoring the need for these efforts. The grants will support telehealth services, transportation for appointments, and training for community doulas, contributing to health equity in the region.
Humana Inc. reported a 4Q22 loss per share of $0.12 on a GAAP basis, with an Adjusted EPS of $1.62. For the full year 2022, EPS was $22.08 (GAAP) and $25.24 (Adjusted). The company projects FY 2023 EPS guidance of at least $27.57 (GAAP) and $28.00 (Adjusted). Humana anticipates individual Medicare Advantage membership growth of at least 625,000, marking a 13.7% increase from 2022. A segment realignment into Insurance and CenterWell is expected to enhance collaboration and growth. Despite reported losses, management expresses confidence in achieving their 2025 Adjusted EPS target of $37.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
